Article thumbnail

Mycobacterium tuberculosis acg Gene Is Required for Growth and Virulence In Vivo

By Yanmin Hu and Anthony R. M. Coates


Mycobacterium tuberculosis dosRS two-component regulatory system controls transcription of approximately 50 genes including hspX, acg and Rv2030c, in response to hypoxia and nitric oxide conditions and within macrophages and mice. The hspX lies between acg and Rv2030c. However, the functions of the dosR regulated genes in vitro and in vivo are largely unknown. Previously, we demonstrated that deletion of hspX gene produced a mutant which grew faster in macrophages and in mice. In this study, we attempted to determine the functions of acg and Rv2030c by gene inactivation. We demonstrate that Rv2030c is dispensable for virulence and growth. However, deletion of acg produced a mutant which is attenuated in both resting and activated macrophages and in acute and persistent murine infection models. Surprisingly, deletion of acg did not compromise the viability of the mutant to nitrosative and oxidative stresses in vitro and in vivo. In addition, when the WT and the acg mutants were treated with antibiotics such as the prodrugs nitrofurantoin and nitrofuran, the acg mutant became more sensitive than the WT strain to these drugs. This suggests that Acg may not function as a nitroreductase. These data indicate that acg encodes an essential virulence factor for M. tuberculosis and enables it to grow and survive in macrophages and in mouse organs

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2003). A family of acr-coregulated Mycobacterium tuberculosis genes shares a common DNA motif and requires Rv3133c (dosR or devR) for expression.
  2. (2009). Acute and Persistent Mycobacterium tuberculosis Infections Depend on the Thiol Peroxidase TPX.
  3. (2000). Bactericidal activity of nitrofurans against growing and dormant Mycobacterium bovis BCG.
  4. (2001). Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates.
  5. (1998). Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.
  6. (2006). Deletion of the Mycobacterium tuberculosis alpha-crystallin-like hspX gene causes increased bacterial growth in vivo.
  7. (2003). Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis.
  8. (1994). Dormancy of Mycobacterium tuberculosis and latency of disease.
  9. (1998). Electroporation of mycobacteria;
  10. (2003). Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence.
  11. (2008). Expression of the Mycobacterium tuberculosis acr-coregulated genes from the DevR (DosR) regulon is controlled by multiple levels of regulation.
  12. (2007). Fridovich I
  13. (2003). Genes required for mycobacterial growth defined by high density mutagenesis.
  14. (2008). Global tuberculosis control : surveillance, planning, financing. Geneva: World Health Organization., viii,
  15. (1991). Hatfull GF
  16. (2008). Heme oxygenase-1-derived carbon monoxide induces the Mycobacterium tuberculosis dormancy regulon.
  17. (2002). Identification of a Mycobacterium tuberculosis putative classical nitroreductase gene whose expression is coregulated with that of the acr aene within macrophages, in standing versus shaking cultures, and under low oxygen conditions.
  18. (2007). Identification of gene targets against dormant phase Mycobacterium tuberculosis infections.
  19. (2007). In silico identification of a new group of specific bacterial and fungal nitroreductases-like proteins.
  20. (2006). Increased pathology in lungs of mice after infection with an alpha-crystallin mutant of Mycobacterium tuberculosis: changes in cathepsin proteases and certain cytokines.
  21. (1998). Mechanisms of latency in Mycobacterium tuberculosis.
  22. (1989). Molecular cloning: a laboratory manual.
  23. (2004). Mycobacterium tuberculosis gene expression during adaptation to stationary phase and low-oxygen dormancy.
  24. (2008). Mycobacterium tuberculosis senses hostderived carbon monoxide during macrophage infection.
  25. (1994). Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens.
  26. (2008). Nitrofurantoin: the return of an old friend in the wake of growing resistance.
  27. (2008). Novel nitrofurazone derivatives endowed with antimicrobial activity.
  28. (2002). Oxidative stress response genes in Mycobacterium tuberculosis: role of ahpC in acg Is Required for Virulence PLoS
  29. (1999). Regulation of hmp gene transcription in Mycobacterium tuberculosis: effects of oxygen limitation and nitrosative and oxidative stress.
  30. (2001). Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin.
  31. (2007). Resazurin reduction assays for screening of antitubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis.
  32. (2009). Role of the dosR-dosS two-component regulatory system in Mycobacterium tuberculosis virulence in three animal models.
  33. (2003). Rv3133c/ dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis.
  34. (1998). The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages.
  35. (2008). The enduring hypoxic response of Mycobacterium tuberculosis.
  36. (2004). The Mycobacterium tuberculosis dosRS two-component system is induced by multiple stresses.
  37. (1999). Transcription of the stationary-phase-associated hspX gene of Mycobacterium tuberculosis is inversely related to synthesis of the 16-kilodalton protein.
  38. (2003). Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages: Insights into the Phagosomal Environment.
  39. (2000). Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement.
  40. (2005). What’s good for the host is good for the bug.